These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6436387)

  • 1. Relationship of arachidonic acid metabolism to indomethacin-sensitive immunoregulatory function and lymphocyte PGE sensitivity in peripheral blood mononuclear cells of disseminated solid tumor cancer patients.
    Braum DP; Harris JE; Rubenstein M
    J Immunopharmacol; 1984; 6(3):227-36. PubMed ID: 6436387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combination chemotherapy on PGE-mediated immunoregulation in the peripheral blood mononuclear cells of solid tumor cancer patients.
    Braun DP; Harris JE
    J Biol Response Mod; 1984 Aug; 3(4):391-6. PubMed ID: 6434702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
    Braun DP; Harris JE
    J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
    Braun DP; Harris JE
    J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.
    Santoli D; Zurier RB
    J Immunol; 1989 Aug; 143(4):1303-9. PubMed ID: 2545787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of cyclosporine induction of increased prostaglandin levels from human peripheral blood monocytes.
    Whisler RL; Lindsey JA; Proctor KV; Morisaki N; Cornwell DG
    Transplantation; 1984 Oct; 38(4):377-81. PubMed ID: 6437025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interferon therapy on indomethacin-sensitive immunoregulation in the peripheral blood mononuclear cells of renal cell carcinoma patients.
    Braun DP; Harris ZL; Harris JE; Sandler S; Khandekar J; Locker G; Haid M; Gordon L; Shaw J; Cobleigh M
    J Biol Response Mod; 1983; 2(3):251-62. PubMed ID: 6196453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of lymphocyte responsiveness to phytohemagglutinin by micromolecular fibrinogen degradation products.
    Janus TJ; Braun DP; Harris JE
    Clin Immunol Immunopathol; 1986 Oct; 41(1):26-34. PubMed ID: 2943545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients.
    Balch CM; Dougherty PA; Cloud GA; Tilden AB
    Surgery; 1984 Jan; 95(1):71-7. PubMed ID: 6229053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of stimulation by human interferon of prostaglandin synthesis in human cell lines.
    Fuse A; Mahmud I; Kuwata T
    Cancer Res; 1982 Aug; 42(8):3209-14. PubMed ID: 6178505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic regulatory properties of the Fc region of immunoglobulin.
    Morgan EL; Scheuer WV; Hobbs MV
    Immunopharmacology; 1986 Dec; 12(3):221-32. PubMed ID: 3102401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin-induced augmentation of lymphoproliferative responses in patients with head and neck cancer.
    McCormick KJ; Panje WR
    Cancer Immunol Immunother; 1986; 21(3):226-32. PubMed ID: 3457630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What regulates placental steroidogenesis in 90-day pregnant ewes?
    Weems YS; Kim L; Tsuda V; Yin C; Weems CW
    Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas.
    Braun DP; Penn RD; Flannery AM; Harris JE
    Neurosurgery; 1982 Feb; 10(2):203-9. PubMed ID: 6280097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial immune testing in surgically resected lung cancer patients.
    Braun DP; Nisius S; Hollinshead A; Harris JE
    Cancer Immunol Immunother; 1983; 15(2):114-20. PubMed ID: 6603261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of arachidonic acid in human maternal and neonatal mononuclear leukocytes.
    Johnsen SA; Olding LB; Green K
    Immunol Lett; 1983 Apr; 6(4):213-8. PubMed ID: 6411611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced production of prostaglandins and plasminogen activator during activation of human articular chondrocytes by products of mononuclear cells.
    Meats JE; McGuire MK; Ebsworth NM; Englis DJ; Russell RG
    Rheumatol Int; 1984; 4(4):143-9. PubMed ID: 6435230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
    Stanojević-Bakić N; Vucković-Dekić L; Susnjar S; Spuzić I
    Neoplasma; 1992; 39(2):129-32. PubMed ID: 1326720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulation by macrophages. III. Prostaglandin E suppresses lymphocyte activation but not macrophage effector function during Salmonella enteritidis infection.
    Cahill J; Hopper KE
    Int J Immunopharmacol; 1984; 6(1):9-17. PubMed ID: 6327542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacin.
    Murray JL; Dowd J; Hersh EM
    J Biol Response Mod; 1986 Feb; 5(1):12-9. PubMed ID: 3485703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.